Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO + Cyclosporine for TD-NSAA
NCT06525948Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2024
- Primary completion
- Jun 2025
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human thrombopoietin in aplastic anemia, sponsored by Peking Union Medical College Hospital. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
recombinant human thrombopoietin
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT06525948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06525948.